PATENT CLAIM ANALYSIS

Application Number: 15977237
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "202000"]

Abstract:
Pharmaceutical compositions comprising ceftibuten or a pharmaceutically acceptable salt thereof, and clavulanic acid or a pharmaceutically acceptable salt thereof are disclosed.

Claim (Index 11):
A pharmaceutical composition according to any of the  claims 1  to  10 , wherein the composition is formulated into a dosage form such that ceftibuten or a pharmaceutically acceptable salt thereof, and clavulanic acid or a pharmaceutically acceptable salt thereof are present in the composition as admixture or as separate components.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15062148', '14808804', '15898453', '15027790', '14111592']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8012563933277622
- 35 USC 102 Novelty (BERT): 0.5243746442958014
- Combined Prediction Score: 0.7735682184245662
- Mean Citation Score: 304.404608
- Max Citation Score: 328.26782000000014
- Similarity Product: 231.34516174536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test